IL-18 serves as a main effector of CAF-derived METTL3 against immunosuppression of NSCLC via driving NF-κB pathway-Reference-Cited by-同舟云学术

IL-18 serves as a main effector of CAF-derived METTL3 against immunosuppression of NSCLC via driving NF-κB pathway

Published:2023-10-23 Issue:1 Volume:18 Page:
ISSN:1559-2294
Container-title:Epigenetics
language:en
Short-container-title:Epigenetics

Author:

Xu Li¹,Li Kang¹,Li Jia¹,Xu Fang¹,Liang Shuzhi¹,Kong Yi¹,Chen Bolin¹

Affiliation:

1. The Second Department of Thoracic Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan Province, P.R. China

Funder

The science and technology innovation Program of Hunan Province

Publisher

Informa UK Limited

Subject

Cancer Research,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15592294.2023.2265625

Reference42 articles.

1. Long non‑coding RNA SLC25A25‑AS1 exhibits oncogenic roles in non‑small cell lung cancer by regulating the microRNA‑195‑5p/ITGA2 axis

2. Long non‐coding RNAs in non‐small cell lung cancer as biomarkers and therapeutic targets

3. Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review

4. Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data

5. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LAMTOR1/mTORC1 promotes CD276 to induce immunosuppression via PI3K/Akt/MMP signaling pathway in Clostridium perfringens–induced necrotic enteritis of laying hens;Poultry Science;2024-12

2. ALKBH5 promotes non-small cell lung cancer progression and susceptibility to anti-PD-L1 therapy by modulating interactions between tumor and macrophages;Journal of Experimental & Clinical Cancer Research;2024-06-14

3. Association between methyltransferase-like 3 and non-small cell lung cancer: pathogenesis, therapeutic resistance, and clinical applications;Translational Lung Cancer Research;2024-05